Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6975352rdf:typepubmed:Citationlld:pubmed
pubmed-article:6975352lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C0597032lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C0080202lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C2362651lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C2745888lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C1554184lld:lifeskim
pubmed-article:6975352lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:6975352pubmed:issue5lld:pubmed
pubmed-article:6975352pubmed:dateCreated1982-1-20lld:pubmed
pubmed-article:6975352pubmed:abstractTextIn the course of analyzing human lymphoma tissue with conventional surface marker techniques and with monoclonal antibodies directed against T cell subsets, five tumors were encountered with dual B and T cell determinants. All bore on their surface membrane IgM of kappa light chain type, complement receptors, and the Ia-like antigen. In each of the five cases, the neoplastic lymphocytes reacted with a monoclonal antibody that detects the sheep erythrocyte receptor (OKT11); all but one reacted with a monoclonal antibody for peripheral T cells (OKT3); and all but one reacted with a monoclonal antibody specific for either the inducer-helper (OKT4) or the cytotoxic-suppressor (OKT8) T cell subsets. In addition, lymphocytes from two of the five cases formed spontaneous rosettes with sheep erythrocytes (E-rosettes). These tumors with dual B and T surface characteristics were confined to human malignant lymphomas that originate from B lymphocytes of the follicle center.lld:pubmed
pubmed-article:6975352pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:languageenglld:pubmed
pubmed-article:6975352pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:citationSubsetIMlld:pubmed
pubmed-article:6975352pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6975352pubmed:statusMEDLINElld:pubmed
pubmed-article:6975352pubmed:monthNovlld:pubmed
pubmed-article:6975352pubmed:issn0022-1007lld:pubmed
pubmed-article:6975352pubmed:authorpubmed-author:AisenbergA...lld:pubmed
pubmed-article:6975352pubmed:authorpubmed-author:BlochK JKJlld:pubmed
pubmed-article:6975352pubmed:authorpubmed-author:WilkerB LBLlld:pubmed
pubmed-article:6975352pubmed:issnTypePrintlld:pubmed
pubmed-article:6975352pubmed:day1lld:pubmed
pubmed-article:6975352pubmed:volume154lld:pubmed
pubmed-article:6975352pubmed:ownerNLMlld:pubmed
pubmed-article:6975352pubmed:authorsCompleteYlld:pubmed
pubmed-article:6975352pubmed:pagination1709-14lld:pubmed
pubmed-article:6975352pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:meshHeadingpubmed-meshheading:6975352-...lld:pubmed
pubmed-article:6975352pubmed:year1981lld:pubmed
pubmed-article:6975352pubmed:articleTitleMalignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.lld:pubmed
pubmed-article:6975352pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6975352pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6975352lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6975352lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6975352lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6975352lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6975352lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6975352lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6975352lld:pubmed